Showing results (81-90 of 203) with videos related to

Sort By:
Pageof 21
Analytical Chemistry|June 24, 2026
Reversible Quantum Dot-Driven Multiplex Technology for <i>In Situ</i> Subcellular Structure ImagingSenke Luo, Xiaochen Tang, Yijie Tang, et al.
Neuropsychiatric Disease and Treatment|May 14, 2024
Sex Differences in Personality Disorder and Childhood Maltreatment of Patients with SchizophreniaXiaoLiang Wang, XiaoDong Ni, YanYan Wei, et al.
Frontiers of Medicine|July 12, 2020
Chimeric antigen receptor T-cell therapy: a promising treatment modality for relapsed/refractory mantle cell lymphomaPing Li, Ningxin Dong, Yu Zeng, et al.
European Archives of Psychiatry and Clinical Neuroscience|August 1, 2021
Temporal and time-frequency features of auditory oddball response in distinct subtypes of patients at clinical high risk for psychosisGuiSen Wu, XiaoChen Tang, RanPiao Gan, et al.
European Archives of Psychiatry and Clinical Neuroscience|January 23, 2023
Attenuated niacin response is associated with a subtype of first-episode drug-naïve psychosis characterized as serious negative symptomsTianHong Zhang, RanPiao Gan, JiaHui Zeng, et al.
General Psychiatry|May 16, 2022
Attenuated niacin-induced skin flush response in individuals with clinical high risk for psychosisRanpiao Gan, Yanyan Wei, Guisen Wu, et al.
Scientific Reports|August 4, 2019
Transdiagnostic Dimensions towards Personality Pathology and Childhood Traumatic Experience in a Clinical Sample: Subtype Classification by a Cross-sectional AnalysisJunJie Wang, Wei Sun, XiaoChen Tang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|June 17, 2024
Dynamic Addressing Molecular Robot (DAMR): An Effective and Efficient Trial-and-Error Approach for the Analysis of Single Nucleotide PolymorphismsTianshu Chen, Guifang Chen, Siyu Cao, et al.
JAMA Network Open|June 6, 2024
Cognitive Impairments in Drug-Naive Patients With First-Episode Negative Symptom-Dominant PsychosisTianHong Zhang, YanYan Wei, XiaoChen Tang, et al.
Schizophrenia Bulletin|May 14, 2024
Advancements and Future Directions in Prevention Based on Evaluation for Individuals With Clinical High Risk of Psychosis: Insights From the SHARP StudyTianHong Zhang, LiHua Xu, YanYan Wei, et al.
Pageof 21